THE Australian Rheumatology Association (ARA) last week issued a warning regarding glucosamine pills, urging patients to stop taking them.
New evidence from the Therapeutic Goods (TGA) Administration has shown the pills fail to help symptoms, with one study revealing patients may be harmed by it.
The TGA's research found 366 "adverse reactions" linked to glucosamine between 2001 and 2011, with the University of Sydney's Institute of Bone and Joint Research David Hunter telling the Sydney Morning Herald the substance was in no way helpful.
"Allergic-type reactions are not uncommon," he said.
"If someone is wondering if they should be on this or if it's helpful for their arthritis, the best clinical evidence would be no."
Representatives_2020_02_13_7508.pdf;fileType=application/pdfRepresentatives_2020_02_13_7508.pdf;fileType=application/pdf
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Feb 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Feb 20
